Looking for Guaranteed Batch Verification
Oral administration is not viablegastric acid and hepatic first-pass metabolism degrade peptide bonds within minutes, rendering the compounds inactive before reaching systemic circulation
LCMS9050-Q-TOF analyses were conducted using similar parameters as in screening method described above, except for the gradient program

Vitamin B12 marketed by Somerset Therapeutics, LLC under NDC Code 70069-005-01 NDC Code(s) : 70069-005-01, 70069-005-10, 70069-172-01, 70069-172-10, 70069-172-25 Packager : Somerset Therapeutics, LLC Category : HUMAN PRESCRIPTION DRUG LABEL DEA Schedule : none Marketing Status : New Drug Application INGREDIENTS AND APPEARANCE LABELER - Somerset Therapeutics, LLC(079947873) REGISTRANT - Somerset Therapeutics, LLC(079947873) PRINCIPAL DISPLAY PANEL Cyanocobalamin Injection, USP 1 mL Container Label NDC 70069-005-01 Container Label Cyanocobalamin Injection, USP 1 mL Carton Label NDC 70069-005-10 Carton Label Cyanocobalamin Injection, USP 10 mL Container Label NDC 70069-172-01 container Label Cyanocobalamin Injection, USP 10 mL Carton Label Pack of 25's NDC 70069-172-25 carton label Cyanocobalamin Injection, USP 10 mL Carton Label Pack of 10's NDC 70069-172-10 carton-label